| Flattening the curve for incarcerated populations—Covid-19 in jails and prisons MJ Akiyama, AC Spaulding, JD Rich New England Journal of Medicine 382 (22), 2075-2077, 2020 | 354 | 2020 |
| Intensive models of hepatitis C care for people who inject drugs receiving opioid agonist therapy: a randomized controlled trial MJ Akiyama, BL Norton, JH Arnsten, L Agyemang, M Heo, AH Litwin Annals of internal medicine 170 (9), 594-603, 2019 | 120 | 2019 |
| Low hepatitis C reinfection following direct-acting antiviral therapy among people who inject drugs on opioid agonist therapy MJ Akiyama, D Lipsey, M Heo, L Agyemang, BL Norton, J Hidalgo, K Lora, ... Clinical Infectious Diseases 70 (12), 2695-2702, 2020 | 61 | 2020 |
| Scedosporium apiospermum infections and the role of combination antifungal therapy and GM-CSF: A case report and review of the literature C Goldman, MJ Akiyama, J Torres, E Louie, SA Meehan Medical mycology case reports 11, 40-43, 2016 | 57 | 2016 |
| Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework MJ Akiyama, N Kronfli, J Cabezas, Y Sheehan, PH Thurairajah, R Lines, ... The lancet Gastroenterology & hepatology 6 (5), 391-400, 2021 | 45 | 2021 |
| Linkage to hepatitis C care after incarceration in jail: a prospective, single arm clinical trial MJ Akiyama, D Columbus, R MacDonald, AO Jordan, J Schwartz, ... BMC Infectious Diseases 19, 1-10, 2019 | 43 | 2019 |
| Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a … MJ Akiyama, CM Cleland, JA Lizcano, P Cherutich, AE Kurth The Lancet Infectious Diseases 19 (11), 1255-1263, 2019 | 40 | 2019 |
| Poor sustained virological response in a multicenter real-life cohort of chronic hepatitis C patients treated with pegylated interferon and ribavirin plus telaprevir or boceprevir KP Vo, P Vutien, MJ Akiyama, VD Vu, NB Ha, JI Piotrowski, J Wantuck, ... Digestive Diseases and Sciences 60, 1045-1051, 2015 | 40 | 2015 |
| Clinical outcomes and inflammatory markers by HIV serostatus and viral suppression in a large cohort of patients hospitalized with COVID-19 VV Patel, UR Felsen, M Fisher, MJ Fazzari, MS Ginsberg, R Beil, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 86 (2), 224-230, 2021 | 38 | 2021 |
| Hepatitis C screening of the “birth cohort”(born 1945–1965) and younger inmates of New York City jails MJ Akiyama, F Kaba, Z Rosner, H Alper, RS Holzman, R MacDonald American journal of public health 106 (7), 1276-1277, 2016 | 34 | 2016 |
| A quality improvement approach to capacity building in low-and middle-income countries J Bardfield, B Agins, M Akiyama, A Basenero, P Luphala, ... Aids 29, S179-S186, 2015 | 34 | 2015 |
| Feasibility of treating hepatitis C in a transient jail population R MacDonald, MJ Akiyama, A Kopolow, Z Rosner, W McGahee, R Joseph, ... Open forum infectious diseases 4 (3), ofx142, 2017 | 33 | 2017 |
| Treatment of chronic hepatitis C in patients receiving opioid agonist therapy: a review of best practice BL Norton, MJ Akiyama, PJ Zamor, AH Litwin Infectious Disease Clinics 32 (2), 347-370, 2018 | 32 | 2018 |
| Correlates of hepatitis C virus infection in the targeted testing program of the New York City jail system: epidemiologic patterns and priorities for action MJ Akiyama, F Kaba, Z Rosner, H Alper, A Kopolow, AH Litwin, H Venters, ... Public Health Reports 132 (1), 41-47, 2017 | 30 | 2017 |
| Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy MJ Akiyama, L Agyemang, JH Arnsten, M Heo, BL Norton, BR Schackman, ... BMC infectious diseases 18, 1-11, 2018 | 29 | 2018 |
| Readmissions in HIV-infected inpatients: a large cohort analysis DJ Feller, MJ Akiyama, P Gordon, BD Agins JAIDS Journal of Acquired Immune Deficiency Syndromes 71 (4), 407-412, 2016 | 28 | 2016 |
| Low adherence achieves high HCV cure rates among people who inject drugs treated with direct-acting antiviral agents BL Norton, MJ Akiyama, L Agyemang, M Heo, I Pericot-Valverde, ... Open Forum Infectious Diseases 7 (10), ofaa377, 2020 | 26 | 2020 |
| Gaps in HCV knowledge and risk behaviors among young suburban people who inject drugs JJ Jost, B Tempalski, T Vera, MJ Akiyama, AP Mangalonzo, AH Litwin International journal of environmental research and public health 16 (11), 1958, 2019 | 26 | 2019 |
| The PREVAIL study: intensive models of HCV care for people who inject drugs AH Litwin, L Agyemang, MJ Akiyama, BL Norton, M Heo, Y Ning, ... J Hepatol 66 (1), S72, 2017 | 26 | 2017 |
| “For the good of mankind": The legacy of nuclear testing in Micronesia S Yamada, M Akiyama Social Medicine 8 (2), 83-92, 2014 | 25 | 2014 |
Moonseong HeoClemson UniversityVerified email at clemson.edu
